Professionals and Partners
Go to Professionals and Partners

Professionals and Partners

Our core expertise is the development and manufacturing of high-quality generic and in-licensed medicines with a proven cost-effectiveness ratio.

Individuals and Families
Go to Individuals and Families

Individuals and Families

We believe in improving the life of individuals and families by using the best current research. We use our resources to drive future scientific and manufacturing development for the constant betterment of therapies.

Home

Tchaikapharma High Quality Medicines Inc. is devoted to providing individuals and families with a wide range of affordable contemporary high-quality pharmaceuticals fighting socially significant diseases.

  • September 9, 2016

    The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companies in Bulgaria. Another pharmaceutical company – Tchaikapharma High Quality Medicines Inc. took the forefront place with a market value of […]

  • September 2, 2016

    On the Bulgarian pharmaceutical market the latest addition to constantly growing product list of Tchaikapharma High Quality Medicines Inc.  for the treatment of cardiovascular diseases is offered from today. The product Cardesart-Co x 30 tablets, an international non-proprietary name Candesartan/Hydrochlorothiazide, in concentrations of active ingredients 8 mg/12.5 mg and 16 mg/12,5 mg registered under the […]

  • August 8, 2016

    A total of 8 among the 40 companies included in calculating one of the main indicators of the Bulgarian Stock Exchange – BGBX40, rose more than 10%, and nine companies lose between 13 and 58% of its market valuation, according to a check made by Profit.bg. Here are the details for the best and worst […]

  • July 19, 2016

    After successfully completing the third for the company Decentralised Procedure (DCP) Tchaikapharma High Quality Medicines Inc. received Marketing Authorisation for the medicinal product Tamayra 5 mg/5 mg hard capsules and Tamayra 10 mg/5 mg hard capsules, for which Bulgaria is the country of reference This is the first international procedure for Marketing Authorisation of medicinal […]

  • July 14, 2016

    Tchaikapharma High Quality Medicines Inc. was granted Marketing Authorisations for the medicinal products Ibodria 6 mg/6 ml concentrate for solution for infusion and Ibodria 3 mg/3 ml solution for injection in pre-filled syringe. The active substance contained is Ibandronic acid (as ibandronate sodium monohydrate). The medicinal product is indicated for the treatment of osteoporosis in […]

  • June 30, 2016

    The Bulgarian Pharmaceutical Union awarded Tchaikapharma High Quality Medicines Inc. for cardiological medicinal product Amariton in the category “Medicinal Product Subject to Medicinal Prescription – made in Bulgaria” for 2016. The Awards ceremony took place at the Tenth anniversary edition of the Bulgarian Pharmaceutical Days, held from the 24th to 26th of June 2016 at […]

  • June 24, 2016

    By decision of the General Meeting, the company’s capital will be increased by BGN 7 million, which will increase in proportion the number of shares that each shareholder has.   On 23rd June 2016, in the presence of the required quorum, was held the Annual General Meeting (AGM) of shareholders of Tchaikapharma High Quality Medicines […]

  • June 22, 2016

    For the past year the company has reported improved results in its financial performance, introducing new products and entering new markets, as well as advancing in the field of its research and development activities   The Public company Tchaikapharma High Quality Medicines Inc. will hold its Annual General Meeting of Shareholders on 23rd of June […]

  • May 13, 2016

    On 10/05/2016, the BDA successfully completed within the specified period the first decentralised procedure (DCP) for marketing authorisation of medicinal products for which Bulgaria is the Reference Member State (RMS). A team of experts from the BDA assessed the documentation, in connection with the Marketing Authorisation of medicinal products Tamayra 5 mg/5 mg hard capsules […]

  • April 8, 2016

    At the end of the trading day (Thursday 7 April) Tchaikapharma’s shares rose most significantly – they increased by 1.21% and the closing price reached BGN 5.85. This represents another appreciation of the emission, which has risen by 6.06% since the beginning of the year.

  • April 7, 2016

    Dear Colleagues,   Happy Holidays!   Your everyday efforts to improve people’s health and save people’s lives are and have always been worthy of respect! All impediments we face with combined efforts every day to ensure that every Bulgarian has the right of access to the most up-to-date treatment and quality life make us not […]

  • March 23, 2016

    Tchaikapharma High Quality Medicines Inc. successfully launched the trading week. On Monday, the company ranked third in traded volume, having trading volume of nearly BGN 33.4 thousand. The transactions were seven, leading to a rise in the share price by 0.7% up to BGN 5.76. On Tuesday, amid the prevailing unprofitable companies on the Stock […]

  • January 11, 2016

    This year again, employees of Commercial League assumed the role of Santa Claus and delighted the kids from Konstantsa Lyapcheva orphanage in the town of Dolna Banya. More than 20 children were asked to send letters with their Christmas wishes, and the team of Commercial League tried to make them true. Besides the dream gift, […]

  • November 6, 2015

    The National Health Service in the UK discontinues the coverage of 25 cancer drugs Twenty five drugs that each year give a last chance to patients with cancer – including breast, prostate and colon cancer will not be funded by the National Health Service in the UK (NHS), which plans to optimize the costs for […]

  • October 20, 2015

    Tchaikapharma High Quality Medicines Inc. was distinguished among the most profitable and influential companies in Bulgaria for the 2014 business rating “300 Business leaders in Bulgaria”. In this year’s forth edition the business analysts from the ICAP Group rated the most successful companies in the country accordingto the Earnings Before Interest, Taxes, Depreciation, and Amortization […]

  • October 6, 2015

    The participants in the National Round Table on Reforms and Healthcare without Restrictions insist that the government restores the principle “the funding follows the patient” “We do not accept and will not accept in the future the activities of the medical institutions to limit and thereby to put bounds on the rights of patients to […]

  • The specialized hospitals of the Bulgarian Cardiac Institute in Varna, Veliko Tarnovo, Shumen and Yambol mark the World Heart Day with an appeal for prevention and free consultations Every year on the 29th of September  the world celebrates the International Heart Day. In connection with this the experts reminded us that according to the “black […]

  • October 2, 2015

    For the first time clinical trials will be conducted to check if a drug prolonged life, said magazine  Sciences et Avenir. The medicine in question is metformin, which is often administered to patients affected by diabetes type 2. In 2008, the study of Russian scientists showed that it prolonged the lives of mice, probably by […]

  • According to Minister Moskov, when one has a facility in the big city where people have assets, one has to take responsibility for the system as well. According to the guild, the solution is to permit subsidiaries Administratively forcible is the method imposed by the state that out of the 4 pharmacies, which an owner […]

  • Doctors specializing in Medicine will have a right to a contract with the NHIF was decided by the MPs yesterday, when they accepted the amendments to the Law on Medical Institutions. This way they made the promise of the Health Minister Petar Moskov, which he made to the doctors in the campaign “Young Medic”, become […]

  • The Health Insurance Fund will finance hospitals only according to the needs of the population The Health Insurance Fund will not finance all newfound hospitals and will base its decisions on the National Health Card, which will have an obligatory nature. It will list the needs of the regional population. This was the bottom-line decision […]

  • September 1, 2015

    For the first time the Republic of Bulgaria, as a Member State of the EU, will be the reference country in the decentralized procedure (DCP) for Marketing Authorisation for a medicinal products with applicant Tchaikapharma High Quality Medicines Inc., Bulgaria. The concerned parties in the procedure are Austria, Greece, Portugal, Romania, Slovakia and the Czech […]

  • July 14, 2015

    Bulgarian Drug Agency issued a new Marketing Authorisation to Tchaikapharma High Quality Medicines Inc. for the medicinal product for treatment of diabetes mellitus Aroba 100 mg tablets. Aroba contains the active substance acarbose, and belongs to the group of medicines called alpha-glucosidase inhibitors. It is used as supplement treatment concomitantly with diet in patients with […]

  • July 13, 2015

    The Guardian wrote that the Scientists had found that two licensed drugs stopped the degeneration of the brain in mice. The discovery gives hope of success in the search for drugs for the therapy of Alzheimer’s disease. The results, presented at the annual conference of scientists researching Alzheimer’s disease, were defined as “promising” because the […]

  • Prof. Marita Eisenmann predicted that after 10 years the fat grifting method will completely replace breast implants. Three women after mammectomy due to breast cancer undergo reconstructive surgery today in Sofia First Gynecological Hospital “St. Sofia” by a Bulgarian team of specialists, led by the world-renowned plastic surgeon Prof. Marita Eisenmann – Klein. This was […]

  • There are reported cases of serious, sometimes life-threatening cases of diabetic ketoacidosis in patients with type 2 diabetes treated with SGLT2-inhibitors. This is reported by the manufacturers after consultation with the European Medicines Agency (EMA) and the Bulgarian Drug Agency (BDA). In a number of these reports the clinical presentation of the condition is atypical, […]

  • During the past 2014 the NHIF allocated 72 million for rare medicines The innovations are crucial for achieving better treatment, but they are very expensive. Good examples of this are the so called “orphan drugs”, which treat rare diseases. Treatment of a patient for a year could exceed millions. Because of that the access is […]

  • A new front in the National Assembly against the reduced requirements for managers was formed. The Health Minister Petar Moskov has proposed a liberalization of the requirements for managers in the Medical Institutions Act and virtually anyone who has a master degree in economics may become head of a hospital. This formed a new front […]

  • The results of a retrospective study published in the Journal of the American College of Cardiology show that the patients with critical limb ischemia who took statins had a significantly lower incidence of major adverse cardiac events (MACE) and amputations. The register of patients with peripheral arterial disease (PAD) from 2006 to 2012 was analized […]

  • July 2, 2015

    Scientists from the Edinburgh University announced that they had found the mechanism that allows breast cancer to spread to the lungs, wrote The Guardian. The team of scientists found that blocking it in mice with the disease reduced the number of secondary tumors in the lungs. The researchers hope that their achievement would lead to […]

  • The party Patriotic Front (PF) would propose a change in the Hospitals Act with which to establish a Register of Medical Errors. This was announced by MP Dr. Sultanka Petrova. Building the system had been discussed for years, leading specialists and the Doctors’ Union had kept demanding that from time to time, but it hadn’t […]

  • The Supervisory Board of the National Health Insurance Fund is expecting from the BMA proposals for solving the problem of clinical pathways overspending. This became clear from the words of the member of the Supervisory Board Dr. Evgeni Tasovski. “We look at where the pain is, and this is the spot that is to be […]

  • Many people called their personal doctors to enroll for a checkup after the Health Minister Dr. Petar Moskov said that if routine preventive checkups were skipped, there should be a higher health insurance, announced the GPs. Even now there is a fine of BGN 50 for skipping the annual checkup provided for in the Health […]

  • Insulin resistance and beta-cell dysfunction are the two key pathophysiological disorders of diabetes mellitus type 2 (DM T2). The liver, muscle and the adipose tissue are resistant to insulin action. The basal hepatic glucose output is increased, despite the high plasma insulin levels, indicating the presence of hepatic insulin resistance. Increased glucose production by the […]

  • June 22, 2015

    The technology was developed by Japanese scientists Japanese scientists have developed technology that allows identifying cancer disease in one drop of blood at an early stage within three minutes, informs RIA Novosti. The technology was developed by Japanese scientists “The technology allows to determine malignancy and to identify the early stage of stomach, colon and […]

  • The World Health Organization (WHO) announced that the viral shedding of the Middle East Respiratory Syndrome (MERS) in South Korea was important, but not a global crisis, reported Reuters the week before. Eight new cases of the disease have been reported in the recent days. 162 people were infected with the virus and 20 people […]

  • Referrals will not be necessary for preventive routine examinations starting 2016 Employees are granted one day paid leave every year to undergo preventive medical examinations. The Health Minister Petar Moskov has already held talks with his colleague Ivaylo Kalfin to allow such a change to the Labour Code. This practice exists in all civilized countries […]

  • At the press conference some days ago the Minister of Health Dr. Peter Moskov stated that at that time the valuation of clinical pathways was like a cat in a bag – no one knew what was in it. He noted that it was unclear how the prices on pathways were formed and what they […]

  • The first health reforms initiated by the government are already happening. With the support of the deputies from the parties Patriotic Front and Alternative for Bulgarian Revival last week were adopted conclusive amendments to the Health Insurance Act, which significantly modify the current system of healthcare. Some of them were met with extreme distrust by […]

  • Metformin is the most commonly used anti-diabetic medicine worldwide. It is generally recognized by experts as the first choice diabetic glucose-lowering drug for glycemic diabetes type 2 (DT2) control – the preferred tool for starting pharmacotherapy according to the international guidelines (the European Association for the Study of Diabetes, the American Diabetes Association and the […]

  • June 17, 2015

    Seemingly healthy skin can contain billions of precancerous cells Mutant cells, capable of causing lethal forms of cancer, hide in the body for years, warn British experts, quoted by the “Daily Express”. The authors of the study from Cambridge University and the Wellcome Trust Sanger Institute found that seemingly healthy and normal functioning skin can […]

  • Swiss scientists have developed a tiny implant that warns of a heart attack a few hours before it takes place. The 14-mm device can be easily implanted under the skin. It regularly measures five indicators, including proteins such as troponin, whose elevated levels signal myocardial injury. The implant sends information to a smartphone or a […]

  • The Health Ministry introduced new specialization rules at the beginning of this year, according to which each clinic is required to conclude an employment contract with the physicians who will work alongside specializing. The aim is to put an end to the free labor of young doctors. The problem is that most young doctors cannot […]

  • Five thousand people less pay contributions to the National Social Security Institute than the people insured in 1993. Bulgarians have been ill almost two times longer in 2014 than in 2003. This is what the data from the National Social Security Institute budget performance since 2003 has shown. 11 years ago the National Social Security […]

  • Due to the lack of quorum on Friday, discussions around the Health Insurance Act will continue early next Wednesday. The idea of splitting the health package into basic and additional has been essentially adopted by a majority in the parliament. On Thursday, the MPs devoted most of their working day to the Health Insurance Act […]

  • Diabetes mellitus is a major risk factor for the development of cardiovascular and cerebrovascular morbidity and mortality. Despite the greater and more widespread “diabetes mellitus” problem awareness and the application of new therapeutic agents in Bulgaria, as in other European countries and the US, the metabolic control of diabetes in more than half the time […]

  • June 1, 2015

    Immunotherapy is one of the experimental methods for tumor treatment. This approach is based on the understanding that a key to the origins, development and outcome of malignant neoplasms is the immune system. In this line of thought, if the functional status of the latter is fortified in the right way, it is likely that […]

  • The system also allows performing Regional Professionals Search The new register of the Bulgarian Medical Association (BMA), which allows any citizen to obtain information about a specific physician, was presented to the Healthcare Commission in the National Assembly last Thursday. The database with public access will allow patients to see where a doctor works, the […]

  • The NHIF has offered the BMA to begin negotiations to reduce clinical pathway prices. The BMA immediately replied that they disagreed, and instead wanted an update of the NHIF budget by BGN 150 million. Obviously, the NHIF is facing increasing pressure to pay more than they have. The problem has become more severe over time […]

  • The manager of the Health Fund Dr. Glinka Komitov had predicted that “based on the current performance towards the end of April, we could expect a deficit in the Health Insurance Fund budget at the end of 2015.” According to the NHIF representative, the deficit is formed by medicines and hospital care, so therefore the […]